Dashboard
1
Poor Management Efficiency with a low ROE of 2.20%
- The company has been able to generate a Return on Equity (avg) of 2.20% signifying low profitability per unit of shareholders funds
2
With ROE of 3.23%, it has a Very Expensive valuation with a 0.93 Price to Book Value
3
Below par performance in long term as well as near term
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-15.28%
0%
-15.28%
6 Months
-29.16%
0%
-29.16%
1 Year
-33.87%
0%
-33.87%
2 Years
-21.06%
0%
-21.06%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%
DSM-Firmenich AG for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
29.55%
EBIT Growth (5y)
13.75%
EBIT to Interest (avg)
7.05
Debt to EBITDA (avg)
0.84
Net Debt to Equity (avg)
0.09
Sales to Capital Employed (avg)
0.37
Tax Ratio
34.43%
Dividend Payout Ratio
264.61%
Pledged Shares
0
Institutional Holding
0.26%
ROCE (avg)
3.39%
ROE (avg)
2.20%
Valuation key factors
Factor
Value
P/E Ratio
29
Industry P/E
Price to Book Value
0.93
EV to EBIT
20.53
EV to EBITDA
10.25
EV to Capital Employed
0.94
EV to Sales
1.73
PEG Ratio
0.14
Dividend Yield
NA
ROCE (Latest)
4.58%
ROE (Latest)
3.23%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
RSI
No Signal
Bullish
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Dow Theory
Bearish
Bearish
OBV
Mildly Bearish
No Trend
Shareholding Snapshot : Dec 2023
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 3 Foreign Institutions (0.31%)
Strategic Entities with highest holding
Highest Public shareholder
Annual Results Snapshot (Consolidated) - Dec'23
Dec'23
Dec'22
Change(%)
Net Sales
10,627.00
8,390.00
26.66%
Operating Profit (PBDIT) excl Other Income
1,314.00
1,377.00
-4.58%
Interest
162.00
67.00
141.79%
Exceptional Items
-514.00
-65.00
-690.77%
Consolidate Net Profit
-636.00
475.00
-233.89%
Operating Profit Margin (Excl OI)
0.70%
86.40%
-8.57%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2023 is 26.66% vs -26.69% in Dec 2022
Consolidated Net Profit
YoY Growth in year ended Dec 2023 is -233.89% vs -46.02% in Dec 2022
About DSM-Firmenich AG 
DSM-Firmenich AG
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






